CAMS-RAS: for Suicide Prevention

Suicide Clinical Trial

— CAMS-RAS  

Official title:

CAMS Relational Agent System for Suicide Prevention

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03072875
• Other study ID #: 1R43MH108222-01A1
• Status: Completed
• Phase: N/A
• Start date: December 18, 2015
• Est. completion date: December 17, 2017

Study information

• Verified date: July 2018
• Source: Evidence-Based Practice Institute, Seattle, WA
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This Phase I feasibility study endeavors to create a prototype of a tool to determine its feasibility with suicidal patients in emergency departments (EDs). This is not a clinical trial. The overarching goal of this research is to create a tool that could reduce suicide rates, increase delivery of efficacious suicide interventions, and decrease overall costs associated with suicidal behaviors. SBIR Phase I project aims include: (1) creating an advisory board to guide the development of CAMS-RAS; (2) iteratively design and develop relational agent ("Dr. Dave") modeled after the gestures, expressions, and mannerisms of CAMS treatment developer, David Jobes, PhD; and (3) conduct feasibility tests to determine whether CAMS-RAS is acceptable, easy to use, and liked by target end-users: acutely suicidal patients admitted to hospital EDs, psychiatric inpatient units, and medical floors for treatment of injuries sustained during a suicide attempt; hospital medical personnel, administrators, and other stakeholders including peer advocates; and outpatient suicidal patients, clinicians and administrators.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 26
• Est. completion date: December 17, 2017
• Est. primary completion date: December 17, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Patient Inclusion Criteria:

• English fluency

• 18 years or older

• receiving clinical care in a hospital or outpatient clinic for suicidality

• Suicidal patients currently admitted to EDs, psychiatric inpatient units, and medical floors, or patient with past (last 6 months) suicidality receiving outpatient treatment

Patient Exclusion Criteria:

• Acutely psychotic

• severely agitated (as determined by care team)

Related Conditions & MeSH terms

• Suicide

Intervention

Device:
• CAMS-RAS

Locations

Country	Name	City	State
United States	Evidence-Based Practice Institute	Seattle	Washington

Sponsors (3)

Lead Sponsor	Collaborator
Evidence-Based Practice Institute, Seattle, WA	The Catholic University of America, University of Florida

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Usability Satisfaction and Acceptability Questionnaire (USAQ)	A brief face-valid, self-report measure that the PI derived from the System Usability Scale and has been successfully used in previous studies. Items are rated on a 5-point Likert Scale (1=poor; 3=good; 5=excellent). Includes open-ended questions to better understand what was most and least helpful with respect to each category and also measures users' acceptance.	up to one day
Primary	Number of ED Patient Participants Who Completed Semi-Structured Interview	A semi-structured interview was conducted following use of the CAMS-RAS tool to assess users' likes, dislikes, and other preferences. Questions included: "What were your experiences in using 'Dr. Dave' and the CAMS-RAS system?" and "What suggestions would you have for improvement?" All subjects indicated that they found the tool helpful to them. They described the tool using adjectives similar to those used to describe "Nurse Louise" - a "discharge nurse" avatar on which the investigator's avatar was based: "He's kind and asks me really practical, helpful questions"; "He speaks to me directly in a compassionate way"; and "He is kind and invested".	After interacting with the technology (length: approximately 1 hour), subjects were then asked to complete the semi-structured interview conducted by the research assistant. On average, the interview lasted approximately 15 minutes.